1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Fusion Protein Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2029 1.2.2 Immunoglobulin (Ig) Fusion Protein 1.2.3 Parathyroid Hormone (PTH) Fusion Protein 1.2.4 Cytokines Recombinant Fusion Protein 1.2.5 Others 1.3 Market by Application 1.3.1 Global Fusion Protein Therapy Market Growth by Application: 2018 VS 2022 VS 2029 1.3.2 Chimeric Protein Drugs 1.3.3 Biological Technology 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 1.6 Years Considered 2 Global Growth Trends 2.1 Global Fusion Protein Therapy Market Perspective (2018-2029) 2.2 Fusion Protein Therapy Growth Trends by Region 2.2.1 Global Fusion Protein Therapy Market Size by Region: 2018 VS 2022 VS 2029 2.2.2 Fusion Protein Therapy Historic Market Size by Region (2018-2023) 2.2.3 Fusion Protein Therapy Forecasted Market Size by Region (2024-2029) 2.3 Fusion Protein Therapy Market Dynamics 2.3.1 Fusion Protein Therapy Industry Trends 2.3.2 Fusion Protein Therapy Market Drivers 2.3.3 Fusion Protein Therapy Market Challenges 2.3.4 Fusion Protein Therapy Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Fusion Protein Therapy Players by Revenue 3.1.1 Global Top Fusion Protein Therapy Players by Revenue (2018-2023) 3.1.2 Global Fusion Protein Therapy Revenue Market Share by Players (2018-2023) 3.2 Global Fusion Protein Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Fusion Protein Therapy Revenue 3.4 Global Fusion Protein Therapy Market Concentration Ratio 3.4.1 Global Fusion Protein Therapy Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Fusion Protein Therapy Revenue in 2022 3.5 Fusion Protein Therapy Key Players Head office and Area Served 3.6 Key Players Fusion Protein Therapy Product Solution and Service 3.7 Date of Enter into Fusion Protein Therapy Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Fusion Protein Therapy Breakdown Data by Type 4.1 Global Fusion Protein Therapy Historic Market Size by Type (2018-2023) 4.2 Global Fusion Protein Therapy Forecasted Market Size by Type (2024-2029) 5 Fusion Protein Therapy Breakdown Data by Application 5.1 Global Fusion Protein Therapy Historic Market Size by Application (2018-2023) 5.2 Global Fusion Protein Therapy Forecasted Market Size by Application (2024-2029) 6 North America 6.1 North America Fusion Protein Therapy Market Size (2018-2029) 6.2 North America Fusion Protein Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029 6.3 North America Fusion Protein Therapy Market Size by Country (2018-2023) 6.4 North America Fusion Protein Therapy Market Size by Country (2024-2029) 6.5 United States 6.6 Canada 7 Europe 7.1 Europe Fusion Protein Therapy Market Size (2018-2029) 7.2 Europe Fusion Protein Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029 7.3 Europe Fusion Protein Therapy Market Size by Country (2018-2023) 7.4 Europe Fusion Protein Therapy Market Size by Country (2024-2029) 7.5 Germany 7.6 France 7.7 U.K. 7.8 Italy 7.9 Russia 7.10 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Fusion Protein Therapy Market Size (2018-2029) 8.2 Asia-Pacific Fusion Protein Therapy Market Growth Rate by Region: 2018 VS 2022 VS 2029 8.3 Asia-Pacific Fusion Protein Therapy Market Size by Region (2018-2023) 8.4 Asia-Pacific Fusion Protein Therapy Market Size by Region (2024-2029) 8.5 China 8.6 Japan 8.7 South Korea 8.8 Southeast Asia 8.9 India 8.10 Australia 9 Latin America 9.1 Latin America Fusion Protein Therapy Market Size (2018-2029) 9.2 Latin America Fusion Protein Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029 9.3 Latin America Fusion Protein Therapy Market Size by Country (2018-2023) 9.4 Latin America Fusion Protein Therapy Market Size by Country (2024-2029) 9.5 Mexico 9.6 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Fusion Protein Therapy Market Size (2018-2029) 10.2 Middle East & Africa Fusion Protein Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029 10.3 Middle East & Africa Fusion Protein Therapy Market Size by Country (2018-2023) 10.4 Middle East & Africa Fusion Protein Therapy Market Size by Country (2024-2029) 10.5 Turkey 10.6 Saudi Arabia 10.7 UAE 11 Key Players Profiles 11.1 Roche 11.1.1 Roche Company Detail 11.1.2 Roche Business Overview 11.1.3 Roche Fusion Protein Therapy Introduction 11.1.4 Roche Revenue in Fusion Protein Therapy Business (2018-2023) 11.1.5 Roche Recent Development 11.2 Abnova 11.2.1 Abnova Company Detail 11.2.2 Abnova Business Overview 11.2.3 Abnova Fusion Protein Therapy Introduction 11.2.4 Abnova Revenue in Fusion Protein Therapy Business (2018-2023) 11.2.5 Abnova Recent Development 11.3 Novus 11.3.1 Novus Company Detail 11.3.2 Novus Business Overview 11.3.3 Novus Fusion Protein Therapy Introduction 11.3.4 Novus Revenue in Fusion Protein Therapy Business (2018-2023) 11.3.5 Novus Recent Development 11.4 Origene 11.4.1 Origene Company Detail 11.4.2 Origene Business Overview 11.4.3 Origene Fusion Protein Therapy Introduction 11.4.4 Origene Revenue in Fusion Protein Therapy Business (2018-2023) 11.4.5 Origene Recent Development 11.5 Chimerigen 11.5.1 Chimerigen Company Detail 11.5.2 Chimerigen Business Overview 11.5.3 Chimerigen Fusion Protein Therapy Introduction 11.5.4 Chimerigen Revenue in Fusion Protein Therapy Business (2018-2023) 11.5.5 Chimerigen Recent Development 11.6 Peprotech 11.6.1 Peprotech Company Detail 11.6.2 Peprotech Business Overview 11.6.3 Peprotech Fusion Protein Therapy Introduction 11.6.4 Peprotech Revenue in Fusion Protein Therapy Business (2018-2023) 11.6.5 Peprotech Recent Development 11.7 Prospec 11.7.1 Prospec Company Detail 11.7.2 Prospec Business Overview 11.7.3 Prospec Fusion Protein Therapy Introduction 11.7.4 Prospec Revenue in Fusion Protein Therapy Business (2018-2023) 11.7.5 Prospec Recent Development 11.8 Aboslute Antibody 11.8.1 Aboslute Antibody Company Detail 11.8.2 Aboslute Antibody Business Overview 11.8.3 Aboslute Antibody Fusion Protein Therapy Introduction 11.8.4 Aboslute Antibody Revenue in Fusion Protein Therapy Business (2018-2023) 11.8.5 Aboslute Antibody Recent Development 11.9 Amgen 11.9.1 Amgen Company Detail 11.9.2 Amgen Business Overview 11.9.3 Amgen Fusion Protein Therapy Introduction 11.9.4 Amgen Revenue in Fusion Protein Therapy Business (2018-2023) 11.9.5 Amgen Recent Development 11.10 Abbvie 11.10.1 Abbvie Company Detail 11.10.2 Abbvie Business Overview 11.10.3 Abbvie Fusion Protein Therapy Introduction 11.10.4 Abbvie Revenue in Fusion Protein Therapy Business (2018-2023) 11.10.5 Abbvie Recent Development 11.11 J & J 11.11.1 J & J Company Detail 11.11.2 J & J Business Overview 11.11.3 J & J Fusion Protein Therapy Introduction 11.11.4 J & J Revenue in Fusion Protein Therapy Business (2018-2023) 11.11.5 J & J Recent Development 11.12 Bristol-Myers Squibb 11.12.1 Bristol-Myers Squibb Company Detail 11.12.2 Bristol-Myers Squibb Business Overview 11.12.3 Bristol-Myers Squibb Fusion Protein Therapy Introduction 11.12.4 Bristol-Myers Squibb Revenue in Fusion Protein Therapy Business (2018-2023) 11.12.5 Bristol-Myers Squibb Recent Development 11.13 Novartis 11.13.1 Novartis Company Detail 11.13.2 Novartis Business Overview 11.13.3 Novartis Fusion Protein Therapy Introduction 11.13.4 Novartis Revenue in Fusion Protein Therapy Business (2018-2023) 11.13.5 Novartis Recent Development 11.14 Merck 11.14.1 Merck Company Detail 11.14.2 Merck Business Overview 11.14.3 Merck Fusion Protein Therapy Introduction 11.14.4 Merck Revenue in Fusion Protein Therapy Business (2018-2023) 11.14.5 Merck Recent Development 11.15 Alexion Pharmaceuticals 11.15.1 Alexion Pharmaceuticals Company Detail 11.15.2 Alexion Pharmaceuticals Business Overview 11.15.3 Alexion Pharmaceuticals Fusion Protein Therapy Introduction 11.15.4 Alexion Pharmaceuticals Revenue in Fusion Protein Therapy Business (2018-2023) 11.15.5 Alexion Pharmaceuticals Recent Development 11.16 Takeda 11.16.1 Takeda Company Detail 11.16.2 Takeda Business Overview 11.16.3 Takeda Fusion Protein Therapy Introduction 11.16.4 Takeda Revenue in Fusion Protein Therapy Business (2018-2023) 11.16.5 Takeda Recent Development 11.17 Biogen 11.17.1 Biogen Company Detail 11.17.2 Biogen Business Overview 11.17.3 Biogen Fusion Protein Therapy Introduction 11.17.4 Biogen Revenue in Fusion Protein Therapy Business (2018-2023) 11.17.5 Biogen Recent Development 11.18 UCB 11.18.1 UCB Company Detail 11.18.2 UCB Business Overview 11.18.3 UCB Fusion Protein Therapy Introduction 11.18.4 UCB Revenue in Fusion Protein Therapy Business (2018-2023) 11.18.5 UCB Recent Development 11.19 Eli Lilly and Company 11.19.1 Eli Lilly and Company Company Detail 11.19.2 Eli Lilly and Company Business Overview 11.19.3 Eli Lilly and Company Fusion Protein Therapy Introduction 11.19.4 Eli Lilly and Company Revenue in Fusion Protein Therapy Business (2018-2023) 11.19.5 Eli Lilly and Company Recent Development 11.20 AstraZeneca 11.20.1 AstraZeneca Company Detail 11.20.2 AstraZeneca Business Overview 11.20.3 AstraZeneca Fusion Protein Therapy Introduction 11.20.4 AstraZeneca Revenue in Fusion Protein Therapy Business (2018-2023) 11.20.5 AstraZeneca Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Fusion Protein Therapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029 Table 2. Key Players of Immunoglobulin (Ig) Fusion Protein Table 3. Key Players of Parathyroid Hormone (PTH) Fusion Protein Table 4. Key Players of Cytokines Recombinant Fusion Protein Table 5. Key Players of Others Table 6. Global Fusion Protein Therapy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029 Table 7. Global Fusion Protein Therapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 Table 8. Global Fusion Protein Therapy Market Size by Region (2018-2023) & (US$ Million) Table 9. Global Fusion Protein Therapy Market Share by Region (2018-2023) Table 10. Global Fusion Protein Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million) Table 11. Global Fusion Protein Therapy Market Share by Region (2024-2029) Table 12. Fusion Protein Therapy Market Trends Table 13. Fusion Protein Therapy Market Drivers Table 14. Fusion Protein Therapy Market Challenges Table 15. Fusion Protein Therapy Market Restraints Table 16. Global Fusion Protein Therapy Revenue by Players (2018-2023) & (US$ Million) Table 17. Global Fusion Protein Therapy Market Share by Players (2018-2023) Table 18. Global Top Fusion Protein Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fusion Protein Therapy as of 2022) Table 19. Ranking of Global Top Fusion Protein Therapy Companies by Revenue (US$ Million) in 2022 Table 20. Global 5 Largest Players Market Share by Fusion Protein Therapy Revenue (CR5 and HHI) & (2018-2023) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Fusion Protein Therapy Product Solution and Service Table 23. Date of Enter into Fusion Protein Therapy Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Fusion Protein Therapy Market Size by Type (2018-2023) & (US$ Million) Table 26. Global Fusion Protein Therapy Revenue Market Share by Type (2018-2023) Table 27. Global Fusion Protein Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million) Table 28. Global Fusion Protein Therapy Revenue Market Share by Type (2024-2029) Table 29. Global Fusion Protein Therapy Market Size by Application (2018-2023) & (US$ Million) Table 30. Global Fusion Protein Therapy Revenue Market Share by Application (2018-2023) Table 31. Global Fusion Protein Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million) Table 32. Global Fusion Protein Therapy Revenue Market Share by Application (2024-2029) Table 33. North America Fusion Protein Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 34. North America Fusion Protein Therapy Market Size by Country (2018-2023) & (US$ Million) Table 35. North America Fusion Protein Therapy Market Size by Country (2024-2029) & (US$ Million) Table 36. Europe Fusion Protein Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 37. Europe Fusion Protein Therapy Market Size by Country (2018-2023) & (US$ Million) Table 38. Europe Fusion Protein Therapy Market Size by Country (2024-2029) & (US$ Million) Table 39. Asia-Pacific Fusion Protein Therapy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029 Table 40. Asia-Pacific Fusion Protein Therapy Market Size by Region (2018-2023) & (US$ Million) Table 41. Asia-Pacific Fusion Protein Therapy Market Size by Region (2024-2029) & (US$ Million) Table 42. Latin America Fusion Protein Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 43. Latin America Fusion Protein Therapy Market Size by Country (2018-2023) & (US$ Million) Table 44. Latin America Fusion Protein Therapy Market Size by Country (2024-2029) & (US$ Million) Table 45. Middle East & Africa Fusion Protein Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 46. Middle East & Africa Fusion Protein Therapy Market Size by Country (2018-2023) & (US$ Million) Table 47. Middle East & Africa Fusion Protein Therapy Market Size by Country (2024-2029) & (US$ Million) Table 48. Roche Company Detail Table 49. Roche Business Overview Table 50. Roche Fusion Protein Therapy Product Table 51. Roche Revenue in Fusion Protein Therapy Business (2018-2023) & (US$ Million) Table 52. Roche Recent Development Table 53. Abnova Company Detail Table 54. Abnova Business Overview Table 55. Abnova Fusion Protein Therapy Product Table 56. Abnova Revenue in Fusion Protein Therapy Business (2018-2023) & (US$ Million) Table 57. Abnova Recent Development Table 58. Novus Company Detail Table 59. Novus Business Overview Table 60. Novus Fusion Protein Therapy Product Table 61. Novus Revenue in Fusion Protein Therapy Business (2018-2023) & (US$ Million) Table 62. Novus Recent Development Table 63. Origene Company Detail Table 64. Origene Business Overview Table 65. Origene Fusion Protein Therapy Product Table 66. Origene Revenue in Fusion Protein Therapy Business (2018-2023) & (US$ Million) Table 67. Origene Recent Development Table 68. Chimerigen Company Detail Table 69. Chimerigen Business Overview Table 70. Chimerigen Fusion Protein Therapy Product Table 71. Chimerigen Revenue in Fusion Protein Therapy Business (2018-2023) & (US$ Million) Table 72. Chimerigen Recent Development Table 73. Peprotech Company Detail Table 74. Peprotech Business Overview Table 75. Peprotech Fusion Protein Therapy Product Table 76. Peprotech Revenue in Fusion Protein Therapy Business (2018-2023) & (US$ Million) Table 77. Peprotech Recent Development Table 78. Prospec Company Detail Table 79. Prospec Business Overview Table 80. Prospec Fusion Protein Therapy Product Table 81. Prospec Revenue in Fusion Protein Therapy Business (2018-2023) & (US$ Million) Table 82. Prospec Recent Development Table 83. Aboslute Antibody Company Detail Table 84. Aboslute Antibody Business Overview Table 85. Aboslute Antibody Fusion Protein Therapy Product Table 86. Aboslute Antibody Revenue in Fusion Protein Therapy Business (2018-2023) & (US$ Million) Table 87. Aboslute Antibody Recent Development Table 88. Amgen Company Detail Table 89. Amgen Business Overview Table 90. Amgen Fusion Protein Therapy Product Table 91. Amgen Revenue in Fusion Protein Therapy Business (2018-2023) & (US$ Million) Table 92. Amgen Recent Development Table 93. Abbvie Company Detail Table 94. Abbvie Business Overview Table 95. Abbvie Fusion Protein Therapy Product Table 96. Abbvie Revenue in Fusion Protein Therapy Business (2018-2023) & (US$ Million) Table 97. Abbvie Recent Development Table 98. J & J Company Detail Table 99. J & J Business Overview Table 100. J & J Fusion Protein Therapy Product Table 101. J & J Revenue in Fusion Protein Therapy Business (2018-2023) & (US$ Million) Table 102. J & J Recent Development Table 103. Bristol-Myers Squibb Company Detail Table 104. Bristol-Myers Squibb Business Overview Table 105. Bristol-Myers Squibb Fusion Protein Therapy Product Table 106. Bristol-Myers Squibb Revenue in Fusion Protein Therapy Business (2018-2023) & (US$ Million) Table 107. Bristol-Myers Squibb Recent Development Table 108. Novartis Company Detail Table 109. Novartis Business Overview Table 110. Novartis Fusion Protein Therapy Product Table 111. Novartis Revenue in Fusion Protein Therapy Business (2018-2023) & (US$ Million) Table 112. Novartis Recent Development Table 113. Merck Company Detail Table 114. Merck Business Overview Table 115. Merck Fusion Protein Therapy Product Table 116. Merck Revenue in Fusion Protein Therapy Business (2018-2023) & (US$ Million) Table 117. Merck Recent Development Table 118. Alexion Pharmaceuticals Company Detail Table 119. Alexion Pharmaceuticals Business Overview Table 120. Alexion Pharmaceuticals Fusion Protein Therapy Product Table 121. Alexion Pharmaceuticals Revenue in Fusion Protein Therapy Business (2018-2023) & (US$ Million) Table 122. Alexion Pharmaceuticals Recent Development Table 123. Takeda Company Detail Table 124. Takeda Business Overview Table 125. Takeda Fusion Protein Therapy Product Table 126. Takeda Revenue in Fusion Protein Therapy Business (2018-2023) & (US$ Million) Table 127. Takeda Recent Development Table 128. Biogen Company Detail Table 129. Biogen Business Overview Table 130. Biogen Fusion Protein Therapy Product Table 131. Biogen Revenue in Fusion Protein Therapy Business (2018-2023) & (US$ Million) Table 132. Biogen Recent Development Table 133. UCB Company Detail Table 134. UCB Business Overview Table 135. UCB Fusion Protein Therapy Product Table 136. UCB Revenue in Fusion Protein Therapy Business (2018-2023) & (US$ Million) Table 137. UCB Recent Development Table 138. Eli Lilly and Company Company Detail Table 139. Eli Lilly and Company Business Overview Table 140. Eli Lilly and Company Fusion Protein Therapy Product Table 141. Eli Lilly and Company Revenue in Fusion Protein Therapy Business (2018-2023) & (US$ Million) Table 142. Eli Lilly and Company Recent Development Table 143. AstraZeneca Company Detail Table 144. AstraZeneca Business Overview Table 145. AstraZeneca Fusion Protein Therapy Product Table 146. AstraZeneca Revenue in Fusion Protein Therapy Business (2018-2023) & (US$ Million) Table 147. AstraZeneca Recent Development Table 148. Research Programs/Design for This Report Table 149. Key Data Information from Secondary Sources Table 150. Key Data Information from Primary Sources List of Figures Figure 1. Global Fusion Protein Therapy Market Size Comparison by Type (2023-2029) & (US$ Million) Figure 2. Global Fusion Protein Therapy Market Share by Type: 2022 VS 2029 Figure 3. Immunoglobulin (Ig) Fusion Protein Features Figure 4. Parathyroid Hormone (PTH) Fusion Protein Features Figure 5. Cytokines Recombinant Fusion Protein Features Figure 6. Others Features Figure 7. Global Fusion Protein Therapy Market Size Comparison by Application (2023-2029) & (US$ Million) Figure 8. Global Fusion Protein Therapy Market Share by Application: 2022 VS 2029 Figure 9. Chimeric Protein Drugs Case Studies Figure 10. Biological Technology Case Studies Figure 11. Others Case Studies Figure 12. Fusion Protein Therapy Report Years Considered Figure 13. Global Fusion Protein Therapy Market Size (US$ Million), Year-over-Year: 2018-2029 Figure 14. Global Fusion Protein Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029 Figure 15. Global Fusion Protein Therapy Market Share by Region: 2022 VS 2029 Figure 16. Global Fusion Protein Therapy Market Share by Players in 2022 Figure 17. Global Top Fusion Protein Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fusion Protein Therapy as of 2022) Figure 18. The Top 10 and 5 Players Market Share by Fusion Protein Therapy Revenue in 2022 Figure 19. North America Fusion Protein Therapy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 20. North America Fusion Protein Therapy Market Share by Country (2018-2029) Figure 21. United States Fusion Protein Therapy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 22. Canada Fusion Protein Therapy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 23. Europe Fusion Protein Therapy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 24. Europe Fusion Protein Therapy Market Share by Country (2018-2029) Figure 25. Germany Fusion Protein Therapy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 26. France Fusion Protein Therapy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 27. U.K. Fusion Protein Therapy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 28. Italy Fusion Protein Therapy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 29. Russia Fusion Protein Therapy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 30. Nordic Countries Fusion Protein Therapy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 31. Asia-Pacific Fusion Protein Therapy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 32. Asia-Pacific Fusion Protein Therapy Market Share by Region (2018-2029) Figure 33. China Fusion Protein Therapy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 34. Japan Fusion Protein Therapy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 35. South Korea Fusion Protein Therapy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 36. Southeast Asia Fusion Protein Therapy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 37. India Fusion Protein Therapy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 38. Australia Fusion Protein Therapy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 39. Latin America Fusion Protein Therapy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 40. Latin America Fusion Protein Therapy Market Share by Country (2018-2029) Figure 41. Mexico Fusion Protein Therapy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 42. Brazil Fusion Protein Therapy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 43. Middle East & Africa Fusion Protein Therapy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 44. Middle East & Africa Fusion Protein Therapy Market Share by Country (2018-2029) Figure 45. Turkey Fusion Protein Therapy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 46. Saudi Arabia Fusion Protein Therapy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 47. Roche Revenue Growth Rate in Fusion Protein Therapy Business (2018-2023) Figure 48. Abnova Revenue Growth Rate in Fusion Protein Therapy Business (2018-2023) Figure 49. Novus Revenue Growth Rate in Fusion Protein Therapy Business (2018-2023) Figure 50. Origene Revenue Growth Rate in Fusion Protein Therapy Business (2018-2023) Figure 51. Chimerigen Revenue Growth Rate in Fusion Protein Therapy Business (2018-2023) Figure 52. Peprotech Revenue Growth Rate in Fusion Protein Therapy Business (2018-2023) Figure 53. Prospec Revenue Growth Rate in Fusion Protein Therapy Business (2018-2023) Figure 54. Aboslute Antibody Revenue Growth Rate in Fusion Protein Therapy Business (2018-2023) Figure 55. Amgen Revenue Growth Rate in Fusion Protein Therapy Business (2018-2023) Figure 56. Abbvie Revenue Growth Rate in Fusion Protein Therapy Business (2018-2023) Figure 57. J & J Revenue Growth Rate in Fusion Protein Therapy Business (2018-2023) Figure 58. Bristol-Myers Squibb Revenue Growth Rate in Fusion Protein Therapy Business (2018-2023) Figure 59. Novartis Revenue Growth Rate in Fusion Protein Therapy Business (2018-2023) Figure 60. Merck Revenue Growth Rate in Fusion Protein Therapy Business (2018-2023) Figure 61. Alexion Pharmaceuticals Revenue Growth Rate in Fusion Protein Therapy Business (2018-2023) Figure 62. Takeda Revenue Growth Rate in Fusion Protein Therapy Business (2018-2023) Figure 63. Biogen Revenue Growth Rate in Fusion Protein Therapy Business (2018-2023) Figure 64. UCB Revenue Growth Rate in Fusion Protein Therapy Business (2018-2023) Figure 65. Eli Lilly and Company Revenue Growth Rate in Fusion Protein Therapy Business (2018-2023) Figure 66. AstraZeneca Revenue Growth Rate in Fusion Protein Therapy Business (2018-2023) Figure 67. Bottom-up and Top-down Approaches for This Report Figure 68. Data Triangulation Figure 69. Key Executives Interviewed

Roche Abnova Novus Origene Chimerigen Peprotech Prospec Aboslute Antibody Amgen Abbvie J & J Bristol-Myers Squibb Novartis Merck Alexion Pharmaceuticals Takeda Biogen UCB Eli Lilly and Company AstraZeneca